Benjamin Brandes, Sophie Hoenke, M. Türk, Björn Weber, H. Deigner, A. Al‐Harrasi, R. Csuk
{"title":"A unified strategy for the synthesis of amorfrutins A and B and evaluation of their cytotoxicity","authors":"Benjamin Brandes, Sophie Hoenke, M. Türk, Björn Weber, H. Deigner, A. Al‐Harrasi, R. Csuk","doi":"10.13171/mjc10902011171546rc","DOIUrl":null,"url":null,"abstract":"3,5-Dimethoxy-benzaldehyde was used as a starting material to synthesize a central intermediate, 2hydroxy-4-methoxy-6-phenethylbenzoic acid that was converted very quickly and with good yields into amorfrutins A and B. Furthermore, this compound was also used as a starting material to synthesize a piperazinylrhodamine B conjugate. The latter compound showed good cytotoxicity (EC50 = 2.3–5.1 M) and promising selective cytotoxicity (S = 2.1–4.6) for human tumor cell lines as compared to non-malignant fibroblasts (NIH 3T3).","PeriodicalId":18513,"journal":{"name":"Mediterranean Journal of Chemistry","volume":"15 1","pages":"858"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mediterranean Journal of Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13171/mjc10902011171546rc","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
3,5-Dimethoxy-benzaldehyde was used as a starting material to synthesize a central intermediate, 2hydroxy-4-methoxy-6-phenethylbenzoic acid that was converted very quickly and with good yields into amorfrutins A and B. Furthermore, this compound was also used as a starting material to synthesize a piperazinylrhodamine B conjugate. The latter compound showed good cytotoxicity (EC50 = 2.3–5.1 M) and promising selective cytotoxicity (S = 2.1–4.6) for human tumor cell lines as compared to non-malignant fibroblasts (NIH 3T3).